Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System

Microbot Medical the developer of the LIBERTY Robotic Surgical System, the first single-use endovascular robotic system, announces another step in its commitment to advance the commercialization processes of LIBERTY with the signing of a manufacturing agreement with B.Y. Medimor Ltd.

Latest ITechnology News: Japan-based Construction Tech Company Log Build Chooses Vonage To Enhance Customer Experience

The agreement governs the manufacturing of the Company’s LIBERTY Robotic Surgical System, for its first in human clinical trial as well as for the initial LIBERTY systems that are expected to be marketed following the completion of regulatory requirements.

Medimor provides new product introduction (NPI) solutions and full turnkey manufacturing for medical devices as a one stop shop contract manufacturing service, including integration, parts cleaning, clean room assembly and testing.

“We continue our transition from a research and development stage to a clinical and commercial stage in the field of endovascular robotics,” commented Simon Sharon, Microbot’s CTO and General Manager. “We believe that the manufacturing agreement supports our efforts to deliver a state-of-the-art advanced robotic system and facilitates our next steps.

Recommended: We Need to Think Differently – Your Hybrid Connectivity Isn’t Really Hybrid

Microbot Medical is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, with the goals of improving clinical outcomes for patients and increasing accessibility through the natural and artificial lumens within the human body.

The LIBERTY Robotic Surgical System aims to improve the way surgical robotics are being used in endovascular procedures by eliminating the need for large, cumbersome, and expensive capital equipment, while reducing radiation exposure and physician strain. The Company believes the LIBERTY Robotic Surgical System’s remote operation has the potential to be the first system to democratize endovascular interventional procedures.

Latest ITechnology News: Teradek To Integrate With Sony’s Ci, Allowing Filmmakers And Broadcasters To Accelerate Secure Camera-to-Cloud Workflow

[To share your insights with us, please write to sghosh@martechseries.com]